PPRCH-14 - A pharmacist care pathway intervention for vascular prevention: Protocol for a randomized controlled trial, PRxOACT

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: PPRCH-14
• By: LIU, Shania (EPICORE, Department of Medicine, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Canada)
• Co-author(s): Dr Shania Liu (EPICORE, Department of Medicine, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada)
  Dr Ross Tsuyuki (EPICORE, Department of Medicine, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada / Department of Medicine, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada / Department of Pharmacology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada)
  Dr Michelle Graham (Department of Medicine, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada)
  Dorothy Nelson
  Gary Semeniuk
  Dr Yazid Al Hamarneh (EPICORE, Department of Medicine, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada / Department of Pharmacology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada)
  
• Abstract:

  Introduction: Cardiovascular disease (CVD) is the leading cause of death worldwide. CVD risk factors are well-known, but treatment gaps persist. Community pharmacist prescribing to lower CVD risk is supported by trials evidence. We developed an electronic tool (“Care Pathway”) for guideline-directed assessment, prescribing & follow-up for CVD..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login